NSE - SMEListed
Accretion Pharmaceuticals Limited

Accretion Pharmaceuticals Limited

Company website
Accretion Pharmaceuticals Limited seeks to raise ₹29,46,000 crore — fresh issue ₹29,46,000 crore, OFS ₹0 crore. Total shares offered: 1200.
Subscribe between 14-05-2025 and 16-05-2025. Allotment is expected on 19-05-2025, with listing on 21-05-2025. Action tip: if you’re unsure, consider starting with a small allocation and review the company’s prospectus.
Start Date14-05-2025
End Date16-05-2025
Listing Date21-05-2025
Allotment Date19-05-2025
Current Price₹79
GMP₹0 (0.00%)
Lot Size1200 Shares
Subscription7.32 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹101 - ₹101
Pre Issue₹81,70,000
Post Issue₹1,11,16,000
Issue Size₹29,46,000
(aggregating up to 29.75 Cr)
Fresh Issue₹29,46,000
(aggregating up to 29.75 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Accretion Pharmaceuticals Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹101 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
25 Nov 2025, 11:07
₹101
₹0
₹101 (0.00%)
12 Nov 2025, 11:09
₹101
₹0
₹101 (0.00%)
03 Nov 2025, 11:23
₹101
₹0
₹101 (0.00%)
17 May 2025, 04:41
₹101
₹0
₹101 (0.00%)
16 May 2025, 11:38
₹101
₹0
₹101 (0.00%)
15 May 2025, 13:32
₹101
₹5
₹106 (4.95%)
14 May 2025, 12:12
₹101
₹16
₹117 (15.84%)
13 May 2025, 17:37
₹101
₹18
₹119 (17.82%)
12 May 2025, 06:21
₹101
₹0
₹101 (0.00%)
09 May 2025, 11:10
₹101
₹0
₹101 (0.00%)
08 May 2025, 05:16
₹101
₹0
₹101 (0.00%)
07 May 2025, 12:22
₹101
₹0
₹101 (0.00%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Accretion Pharmaceuticals Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIDec-24Mar-24Mar-23
EPS
8.74
9.69
0.26
ROE
38.54
72.47
2.70
ROCE
30.14
36.73
9.87
RONW
38.54
72.47
2.70
PRE IPO(PE)
0
21.29
0
POST IPO(PE)
16.08
0
0

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹1.43
17.37
12.15
RETAIL
₹12.35
130.24
10.55
Total
₹13.78
147.61
10.71

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
QIB
NaN
4
0.00
NIB
NaN
889
0.00
RETAIL
NaN
10,746
0.00
Total
0
0
0.00
The IPO reservation for Accretion Pharmaceuticals Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
RETAIL
41.51%
12,22,800
NII(HNI)
41.51%
12,22,800
Anchor
7.17%
2,11,200
QIB
4.81%
1,41,600
Market Maker
5.01%
1,47,600
TOTAL
100.00%
29,46,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
1
1,200
₹1,21,200
0
HNI
2
2,400
₹2,42,400
0
Below you can find the official contact details of Accretion Pharmaceuticals Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91-97148 82929
Address: 29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad Sanand

IPO Registrar

Name: Kfin Technologies Limited
Phone: 04067162222
Accretion Pharmaceuticals Limited IPO Details — GMP: ₹0 (0.00%) | Grey Market IPO